Skip to main content
SpringerLink
Log in

Adjuvant Medications for Pain in the Rehabilitation Patient

  • Chapter
  • First Online:
Comprehensive Pain Management in the Rehabilitation Patient

  • 1673 Accesses

Abstract

This chapter will cover adjuvant, non-opioid medications used for pain management in the rehabilitation patient. This chapter is exclusive of opioids and psychiatric drugs usedfor pain, which are described in subsequent chapters. Adjuvant medications are non-opioid drugs used for pain, which can be incorporated as part of a multimodal, multidisciplinary pain management program.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Macintyre PE, Scott DA, Schug SA, et al., editors. Acute pain management: scientific evidence. 3rd ed. Melbourne: Australian and New Zealand College of Anesthetists; 2010.

    Google Scholar 

  2. Auret K, Schug SA. Pain management for the cancer patient—current practice and future developments. Best Pract Res Clin Anaesthesiol. 2013;27:545–61.

    PubMed  Google Scholar 

  3. Gaskin DJ, Richard P, editors. The economic costs of pain in the United States. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press (US); 2011.

    Google Scholar 

  4. Rosenbaum A, Marsch L. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol. 2008;16(5):405–16.

    Google Scholar 

  5. Schug S, Goddard C. Recent advances in the pharmacological management of acute and chronic pain. Ann Palliat Med. 2014;3(4):263–75.

    PubMed  Google Scholar 

  6. Management of chronic pain syndromes: issues and interventions. Pain Med. 2005;6:S1–21.

    Google Scholar 

  7. Treed RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.

    Google Scholar 

  8. IASP Taxonomy—IASP. Philadelphia: Lippincott Williams & Wilkins. Available at: http://www.iasp-pain.org/Taxonomy.

  9. Green S, Buchbinder R, Barnsley L, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults. Cochrane Database Syst Rev. 2002;4:CD003686.

    Google Scholar 

  10. Schumacher M, Pasvankas G. Topical capsaicin formulations in the management of neuropathic pain. Prog Drug Res. 2014;68:105–28.

    CAS  PubMed  Google Scholar 

  11. Mick G, Correa-Illanes G. Topical pain management with the 5% lidocaine medicated plaster—a review. Curr Med Res Opin. 2012;28:937–51.

    CAS  PubMed  Google Scholar 

  12. Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237–51.

    CAS  PubMed  Google Scholar 

  13. Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305.

    CAS  PubMed  Google Scholar 

  14. Campbell BJ, Rowbotham M, Davies PS, et al. Systemic absorption of topical lidocaine in normal volunteers, patients with post-herpetic neuralgia, and patients with acute herpes zoster. J Pharm Sci. 2002;91:1343–50.

    CAS  PubMed  Google Scholar 

  15. Cheville AL, Sloan JA, Northfelt DW, et al. Use of a lidocaine patch in the management of post surgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer. 2009;17:451–60.

    PubMed  PubMed Central  Google Scholar 

  16. Ho KY, Huh BK, White WD, Yeh CC, Miller EJ. Topical amitryptilline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 2008;24:51–5.

    PubMed  Google Scholar 

  17. Argon CE. Topical analgesics in the management of acute and chronic pain. Mayo Clin Proc. 2013;88(2):195–205.

    Google Scholar 

  18. Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2012;9:CD010111.

    Google Scholar 

  19. Derry S, Sven-Rice A, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2013;2:CD007393.

    Google Scholar 

  20. Graham GG, Davies MJ, Day RO, et al. The modern pharmacology of paracetamol; therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21:201–32.

    CAS  PubMed  Google Scholar 

  21. Blieden M, Paramore LC, Shad D, et al. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol. 2014;7:341–8.

    CAS  PubMed  Google Scholar 

  22. Dart RC, Bailey E. Does therapeutic use of acetaminophen cause acute liver failure? Pharmacotherapy. 2007;27:1219–30.

    CAS  PubMed  Google Scholar 

  23. Hughes GJ, Patel PN, Saxena N. Effect of acetaminophen on international normalized ration in patients receiving warfarin therapy. Pharmacotherapy. 2011;31:591–7.

    CAS  PubMed  Google Scholar 

  24. Choueiri TK, Je Y, Cho E. Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiological studies. Int J Cancer. 2014;134:384–96.

    PubMed  Google Scholar 

  25. Etminan M, Sadatsafvi M, Jafari S, et al. Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest. 2009;136:131–23.

    Google Scholar 

  26. Eyers S, Weatherill M, Jeffries S, et al. Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy. 2011;41:482–9.

    CAS  PubMed  Google Scholar 

  27. Tzortzopoulou A, McNicol ED, Cepeda MS, et al. Single dose intravenous propacetamol or intravenous paracetamol for postoperative pain. Cochrane Database Syst Rev. 2011;10:CD007126.

    Google Scholar 

  28. Apfel CC, Turan A, Souza K, et al. Intravenous acetaminophen reduces postoperative nausea and vomiting; a systematic review and meta-analysis. Pain. 2013;154:677–89.

    CAS  PubMed  Google Scholar 

  29. Rousing J, Moiniche S, Mathiesen O, et al. Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation; a systematic review. Acta Anaesthesiol Scand. 2005;49:133–42.

    Google Scholar 

  30. Kehlet H, Rung GW, Callesen T. Postoperative opioid analgesia: time for a reconsideration? J Clin Anesth. 1996;8(6):441–5.

    CAS  PubMed  Google Scholar 

  31. Van Tulder MW, Scholten RJ, Koes BW, et al. Nonsteroidal anti-inflammatory drugs for low back pain. Spine (Phila Pa 1976). 2000;25(19):2501–13.

    CAS  PubMed  Google Scholar 

  32. Myers J, Wielage RC, Han B, et al. The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis. BMC Musculoskelet Disord. 2014;15(1):76.

    PubMed  PubMed Central  Google Scholar 

  33. Dreiser R, Le Parc J, Velicitat P, et al. Oral meloxicam is effective in acute sciatica: two randomized, double-blind trials versus placebo or diclofenac. Inflamm Res. 2001;50:S17–23.

    CAS  PubMed  Google Scholar 

  34. He A, Hersh EV. A review of intranasal ketorolac tromethamine for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. Curr Med Res Opin. 2012;28:1873–80.

    CAS  PubMed  Google Scholar 

  35. Gibofsky A, Hochberg MC, Karos MJ, et al. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Curr Med Res Opin. 2014;30:1883–93.

    CAS  PubMed  Google Scholar 

  36. Manvelian G, Hochberg MC, Daniels SE, et al. A phase 2 study of lower-dose, indomethacin submicron particle capsules demonstrates early onset of acute pain relief. Clin J Pain. 2014;30:846–51.

    PubMed  Google Scholar 

  37. Gan TJ, Daniels SE, Singla N, et al. A novel injectable formulation of diclofenac compares with intravenous ketorolac or placebo for acute moderate-to-severe pain after abdominal or pelvic surgery: a multi center, double-blind, randomized, multiple-dose study. Anesth Analg. 2012;115:1212–20.

    CAS  PubMed  Google Scholar 

  38. Wiffen PJ, Derry S, Moore RA, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia—an overview of Cochrane reviews. Cochrane Database Syst Rev. 2013;11:CD010567.

    Google Scholar 

  39. Snedecor SJ, Susharshan L, Cappelleri JC, et al. Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions. Int J Clin Pract. 2014;68:900–18.

    CAS  PubMed  Google Scholar 

  40. Snedecor SJ, Sudarshan L, Cappelleri JC, et al. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract. 2014;14:167–84.

    PubMed  Google Scholar 

  41. Mehta S, McIntyre A, Dijkers M, et al. Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis. Arch Phys Med Rehabil. 2014;95:2180–6.

    PubMed  Google Scholar 

  42. O’Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009;122:S22–32.

    PubMed  Google Scholar 

  43. Uceyler N, Sommer C, Walitt B, et al. Anticonvulsants for fibromyalgia. Cochrane Database Syst Rev. 2013;10:CD010782.

    Google Scholar 

  44. Gray P. Acute neuropathic pain: diagnosis and treatment. Curr Opin Anaesthesiol. 2008;21:590–5.

    PubMed  Google Scholar 

  45. Gray P, Kirby J, Smith MT, et al. Pregabalin in severe burn injury pain: a double-blind, randomised placebo-controlled trial. Pain. 2011;152:1279–88.

    CAS  PubMed  Google Scholar 

  46. Backonja M. Use of anticonvulsants for the treatment of neuropathic pain. Neurology. 2002;59(5 Suppl 2):S14–7.

    PubMed  Google Scholar 

  47. Zakrzewska JM. Medical management of trigeminal neuropathic pains. Expert Opin Pharmacother. 2010;11:1239–54.

    CAS  PubMed  Google Scholar 

  48. Wife PJ, Derry S, Moore RA. Lamotrigdine for acute and chronic pain. Cochrane Database Syst Rev. 2011;2:CD006044.

    Google Scholar 

  49. Hearn L, Derry S, Moore RA. Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;2:CD009318.

    Google Scholar 

  50. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathy pain. Pain. 2010;150:573–81.

    PubMed  Google Scholar 

  51. Cui M, Li Z, You S, et al. Mechanisms of the antinociceptive effect of subcutaneous Botox: inhibition of peripheral and central nociceptive processing. Arch Pharmacol. 2002;365:R17.

    Google Scholar 

  52. Lew M. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain. 2002;18:S142–6.

    PubMed  Google Scholar 

  53. Soares A, Andriolo RB, Atallak AN, et al. Botulinum toxin for myofascial pain syndromes in adults. J Pain Palliat Care Pharmacother. 2012;26(7):283.

    Google Scholar 

  54. Singh JA. Use of botulinum toxin in musculoskeletal pain. F1000Res. 2013;2:52.

    PubMed  PubMed Central  Google Scholar 

  55. Staats PS, Presley RW, Wallace MS, et al. Intrathecal ziconatide in the treatment of refractory pain in patients with cancer and AIDS: a randomized controlled trial. JAMA. 2004;291(1):63–70.

    CAS  PubMed  Google Scholar 

  56. Wallace MS, Charapata SG, Fisher R, et al. Intrathecal ziconatide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial. Neuromodulation. 2006;9(2):75–86.

    PubMed  Google Scholar 

  57. Abramaowicz M. Tramadol—a new oral analgesic. Med Lett Drugs Ther. 1993;37:59–62.

    Google Scholar 

  58. Hollingshead J, Duhmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2006;(3):CDOO3726.

    Google Scholar 

  59. Nesters M, Mroto PL, Aarts L, et al. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth. 2014;113:148–56.

    Google Scholar 

  60. Riemima R, Forbes C, Harker J, et al. Systematic review of tepentadol in chronic severe pain. Curr Med Res Opin. 2011;27:1907–30.

    Google Scholar 

  61. Merchant S, Provenzano D, Mody S, et al. Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: pooled analysis of randomized studies. J Opioid Manag. 2013;9:51–61.

    PubMed  Google Scholar 

  62. Liu SS, Hodgson PS. Local anesthetics. In: Brash PG, Cullen BF, Stoelting RF, editors. Clinical anesthesia. Philadelphia: Lippincott-Raven; 2006. p. 453–71.

    Google Scholar 

  63. Miller RD, Pardo MC. Basics of anesthesia. 6th ed. Philadelphia: Elsevier/Churchill Livingstone; 2011. p. 130–42.

    Google Scholar 

  64. Raja SN, Fishman S, Liu S, et al. Benzon essentials of pain medicine and regional anesthesia. 2nd ed; 2005. p. 558–65.

    Google Scholar 

  65. Chan AKM, Cheung CW, Chong YK. Alpha-2 agonists in acute pain management. Expert Opin Pharmacother. 2010;11:2849–68.

    CAS  PubMed  Google Scholar 

  66. Visser E. A review of calcitonin and its use in the treatment of acute pain. Acute Pain. 2005;7:143–8.

    Google Scholar 

  67. McCormick Z, Change-Chien G, Marshall B, et al. Phantom limb pain: a systematic neuroanatomical-based review of pharmacologic treatment. Pain Med. 2014;15:292–305.

    PubMed  Google Scholar 

  68. Tian S, Nick S, Wu H. Phantom limb pain: a review of evidence-based treatment options. World J Anesthesiol. 2014;3:146–53.

    Google Scholar 

  69. Knopp-Sihota JA, Newburn-Cook CV, Homik J, et al. Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fracture: a systematic review and meta-analysis. Osteoporos Int. 2012;23:17–38.

    CAS  PubMed  Google Scholar 

  70. Hill L, Schug SA. Recent advances in the pharmaceutical management of pain. Expert Rev Clin Pharmacol. 2009;2:543–57.

    CAS  PubMed  Google Scholar 

  71. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials. Br J Clin Pharmacol. 2011;72:735–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Beal BR, Wallace MS. An overview of pharmacologic management of chronic pain. Med Clin North Am. 2016;100:65–79.

    PubMed  Google Scholar 

  73. Chessell IP, Dudley A, Billinto A. Biologics: the next generation of analgesic drugs? Drug Discov Today. 2012;17:875–9.

    CAS  PubMed  Google Scholar 

  74. Steiman AJ, Pope JE, Thiessen-Phillbrrok H, et al. Non-biologic disease modifying anti rheumatic drugs (DMARDS) improve pain in inflammatory arthritis: a systematic review of randomized controlled trials. Rheumatol Int. 2013;33:1105–20.

    CAS  PubMed  Google Scholar 

  75. Laska EM, Sunshine A, Mueller F, et al. Caffeine as an adjuvant analgesic. JAMA. 1986;251:45–50.

    Google Scholar 

  76. Forrest WH, Brown BW, Brown CR, et al. Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med. 1977;296:712–5.

    PubMed  Google Scholar 

  77. Leppert W, Buss T. The role of corticosteroid in the treatment of pain in cancer patients. Curr Pain Headache Rep. 2012;16:307–13.

    PubMed  PubMed Central  Google Scholar 

  78. Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007;147:505–14.

    PubMed  Google Scholar 

  79. See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008;28:207–13.

    CAS  PubMed  Google Scholar 

  80. Goetz CG, Pappert EJ. Textbook of clinical neurology. Philadelphia, PA: W.B. Saunders; 2007.

    Google Scholar 

  81. Katz RT. Spasticity. In: O’Young B, Young MA, Stiens SA, editors. PM&R secrets. Philadelphian, PA: Hanley & Belfus; 1997.

    Google Scholar 

  82. Elovic E, Baerga E, Escaldi SV. In: Cuccurullo SJ, editor. Physical medicine and rehabilitation board review. 3rd ed. New York, NY: Demos Medical; 2015.

    Google Scholar 

  83. Petrenko AB, Kamakura T, Baba H, et al. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108–16.

    CAS  PubMed  Google Scholar 

  84. Hirota K, Lambert DG. Ketamine: new uses for an old drug? Br J Anesth. 2011;107:123–6.

    CAS  Google Scholar 

  85. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg. 2003;97:1730–9.

    CAS  PubMed  Google Scholar 

Recommended Reading

  • Irving G, Wallace M. Pain management for the practicing physician. New York: W.B. Sunders; 1996. p. 37–47.

    Google Scholar 

  • McMahon SB, Koltzenburg M, Tracey I, et al., editors. Wall and Melzack’s textbook of pain. 6th ed. Philadelphia, PA: Elsevier Saunders; 2013.

    Google Scholar 

  • Miller RD, Pardo MC. Basics of anesthesia. 6th ed. Philadelphia: Elsevier/Churchill Livingstone; 2011.

    Google Scholar 

  • Raja SN, Fishman S, Liu S, et al. Benzon essentials of pain medicine and regional anesthesia. 2nd ed; 2005. p. 558–65.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pain, Rehabilitation Medicine, Department of Neurosurgery, Comprehensive Spine Center, Rhode Island Hospital, Brown University, 593 Eddy Street, George 1st Fl., Providence, RI, 02903, USA

    Alexios Carayannopoulos D.O., M.P.H.

Authors
  1. Alexios Carayannopoulos D.O., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexios Carayannopoulos D.O., M.P.H. .

Editor information

Editors and Affiliations

  1. Department of Neurosurgery, Brown University, Warren Alpert Medical School, Providence, USA

    Alexios Carayannopoulos DO, MPH

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Carayannopoulos, A. (2017). Adjuvant Medications for Pain in the Rehabilitation Patient. In: Carayannopoulos DO, MPH, A. (eds) Comprehensive Pain Management in the Rehabilitation Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-16784-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16784-8_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16783-1

  • Online ISBN: 978-3-319-16784-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation